Physician profile
Ravi Kapadia
NPI 1669736427
$73,043.64
in general payments reported to CMS, 2019-2025
18 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,214 · 2020: $5,392 · 2021: $368 · 2022: $607 · 2023: $34K · 2024: $30K · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $49K · Travel and Lodging: $11K · Food and Beverage: $3,980.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $49,002.50 |
| Travel and Lodging | $11,479.89 |
| Food and Beverage | $3,979.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $63,415.65 | 2022-2025 | Puraply Wound Matrix, Puraply, Puraply Antimicrobial |
| Intuitive Surgical, INC. | $4,429.94 | 2020 | |
| Endologix LLC | $2,019.50 | 2019 | |
| Zimmer Biomet Holdings, INC. | $690.47 | 2020 | |
| Medtronic, INC. | $377.53 | 2023-2024 | Intellis Adaptivestim, Accurian |
| Nevro Corp. | $345.80 | 2021-2023 | Senza |
| Alphatec Spine, INC | $311.97 | 2024 | Solus Alif |
| Smith+Nephew, INC. | $288.77 | 2022-2025 | Collagenase Santyl |
| Integra Lifesciences Corporation | $281.36 | 2021 | |
| Cook Medical LLC | $194.27 | 2019 | |
| Ethicon US, LLC | $186.03 | 2020-2021 | |
| Sanara Medtech INC. | $150.91 | 2024-2025 | Celleraterx, Celleraterx |
| Coloplast Corp | $126.61 | 2024 | |
| Acell, INC. | $79.32 | 2020 | |
| Innovation Technologies INC | $47.30 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $42.26 | 2025 | Novosorb Btm |
| Vertex Pharmaceuticals Incorporated | $33.75 | 2025 | |
| Allergan, INC. | $22.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Kapadia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.